Latest Leadership Appointments News

Finexia Financial Group has resumed trading following announcements of a significant business disposal and new executive appointments, signaling a pivotal restructuring phase.

TasFoods reported a 19.9% revenue decline in Q2 2025 amid persistent poultry oversupply and discounted prices in Tasmania, while advancing strategic initiatives to stabilize operations and improve shareholder returns.

Ovanti Limited has appointed Peter Maher, a seasoned BNPL executive from Zip Co, to lead its US expansion, while exploring a NASDAQ listing via dual-listing or SPAC merger and reconsidering the sale of a key dividend-yielding asset.

Asra Minerals has completed a major drilling campaign at its Leonora South Gold Project and secured $3 million in fresh capital to fast-track exploration, alongside key leadership appointments and strategic asset realignments.

Marquee Resources has progressed its Mt Clement antimony-gold project with Phase 1 drilling completed and assay results pending, alongside a $596,000 capital raise and a key executive appointment.

Imugene Limited reports strong clinical progress with its off-the-shelf CAR T therapy azer-cel achieving a 75% overall response rate in Phase 1b trials, alongside new patents and leadership appointments. The company also secured $22.5 million in fresh funding to advance pivotal trials.

American Rare Earths Limited reports strong progress at its Halleck Creek Rare Earths Project, highlighted by exceptional sampling results, key permitting milestones, and a $15 million equity raise to fund development.

Harvest Technology Group reports a 135% revenue increase in Q4 FY25, new leadership appointments, and a strategic listing on the Frankfurt Stock Exchange to broaden its investor base.

PVW Resources Limited has appointed David Wheeler as Non-Executive Chairman while director Colin McCavana has resigned, marking a notable shift in the company’s leadership.

RemSense Technologies closed FY2025 with a positive EBITDA and expanding virtualplant platform usage among major clients, setting the stage for significant growth in FY2026. The company’s strategic hires and new contracts highlight its rising footprint in industrial digital transformation.

Tolu Minerals reports significant progress at its Tolukuma Gold Mine, unveiling infrastructure upgrades and a $14.3 million exploration program aimed at boosting production and extending mine life.

Arovella Therapeutics reported a robust $20.9 million cash position as it prepares for its first-in-human trial of ALA-101 and expands its solid tumour pipeline through new licensing agreements and leadership appointments.